Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

August 7, 2025

Primary Completion Date

August 1, 2026

Study Completion Date

November 1, 2026

Conditions
Heart FailureICUAW
Interventions
DIAGNOSTIC_TEST

transthoracic echocardiography

"Transthoracic echocardiography (TTE) is a non-invasive method for assessing cardiac morphology and function. As part of the study protocol, TTE will be performed at the time of study inclusion (within the first 24 hours after ICU admission), on day 3, day 7, and day 14, followed by weekly assessments (until discharge from the ICU), as well as on the day of planned ICU or hospital discharge.~To verify skeletal muscle mass in relation to myocardial mass and its changes over the course of the ICU stay, bioelectrical impedance analysis (BIA) will be performed at the time points mentioned above."

Trial Locations (2)

1090

RECRUITING

Medical University of Vienna, Vienna

10117

RECRUITING

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
collaborator

Medical University of Vienna

OTHER

lead

Charite University, Berlin, Germany

OTHER

NCT07094425 - Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study | Biotech Hunter | Biotech Hunter